New blood-clot drugs may add to gastrointestinal bleeding risk

07/22/2013 | PhysiciansBriefing.com

Gastrointestinal bleeding is more likely to occur with newer oral anticoagulants than with standard treatment, according to an analysis in the journal Gastroenterology. Researchers analyzed data on 151,578 patients who participated in 43 randomized, controlled studies and found that the risk was greatest for those undergoing therapy for venous thrombosis and acute coronary syndrome. "The current evidence, however, is based on a highly selected patient group with a low bleeding risk, disallowing a true reflection of future patients in daily clinical practice," researchers wrote.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC